Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2026-09-11 11:07:53 ET · period of report 2026-09-09 · accession 0001214659-26-011596 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-11 11:07 | 2026-09-09 | AQST | Korczynski Sherry | Chief Commercial Off | M - OptEx | $2.65 | +8,750 | 244.4K | +4% | +$23.2K |
| DT | 2026-09-11 11:07 | 2026-09-09 | AQST | Korczynski Sherry | Chief Commercial Off | S - Sale+OE | $5.22 | -8,750 | 235.7K | -4% | -$45.7K |
| DT | 2026-09-11 11:07 | 2026-09-09 | AQST | Korczynski Sherry | Chief Commercial Off | M - OptEx | $0.00 | -8,750 | 26.2K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-09 | M | A | 8,750 | $2.65 | 244,439 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-09 | S | D | 8,750 | $5.22 | 235,689 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-09-09 | M | D | 8,750 | $0.00 | 26,250 | D | $2.65 · — to 2035-03-07 | 8,750 Common Stock | (F2) The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |